LONDON, Aug. 25, 2015 /PRNewswire/ -- Scope of the Report
The report titled "Global In-Vitro-Fertilization (IVF) Market: Trends and Opportunities (2015-2019)", analyzes the potential opportunities and significant trends in the global in- vitro-fertilization market. The market size and forecast in value terms and number of IVF cycles for global IVF market has been provided for the period 2010 to 2019, considering 2014 as the base year. The report provides market share analysis of the global IVF market by regions, treatment costs, players and segments. The market is further segment by drug mechanism and different dosage forms.
The report provides detailed country analysis of the IVF markets of Australia, India and the United States. The market size and forecast both in terms of value and volume is covered in the country analysis segment. Also, the various factors driving growth have been analyzed specific to each country.
The report also profiles key market players such as Vitrolife, Monash IVF and OvaScience on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments.
- United States
- Monash Group
IVF stands for in-vitro-fertilization and refers to artificial fertilization for people that want to have a baby but are having difficulty getting pregnant.
Rising incidences of infertility as a consequence of increasing maternal age as more women are now starting families later in life is leading to a rise in demand for IVF treatment. Furthermore, lifestyle induced disorders such as obesity and smoking are contributing towards high infertility rates. These together are thus driving the in-vitro fertilization market, as women and their families prefer in-vitro fertilization procedure more compared to the other available procedures. The global in-vitro fertilization market is also witnessing lucrative growth with an increase in medical tourism activities in the developing economies such as India, China and Brazil. The major limiting factor of IVF market is the cost involved in the treatment. Another challenge is the low level of awareness in the developing economies.
The US emerged as the highest revenue contributing regional market for IVF in 2013. The growth of this market in the region is attributed to the presence of large population base suffering from infertility. Moreover, the availability of high disposable income with the people of this region is contributing to the growth of the IVF market. Asia Pacific is expected to grow at a highest CAGR over the forecasted period of 2015-2019 because of the presence of unmet medical needs coupled with favorable government initiatives pertaining to the development of healthcare infrastructure in emerging economies such as India, China and Japan. Australia has the highest market value and number of IVF cycles in the Asia-Pacific region. Furthermore, increasing medical tourism and availability of cost effective medical procedures in India are expected to positively reinforce In-Vitro fertilization market.
Download the full report: https://www.reportbuyer.com/product/3186635/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers